Tumor Markers
Tumor Markers is a class of biochemical substances, typically proteins or enzymes, whose abnormal concentration in the body fluids or tissues serves as an indicator of neoplastic activity, distinguishing it from other clinical biomarkers by its specific association with tumor presence, progression, or response to therapy.
35.2K
Publications
1.9M
Citations
153.4K
Authors
11.3K
Institutions
Publications per year
2017–2026
7.7K
35.2K
Xi Chen, Yi Ba, Lijia Ma et al. · Cell Research · 2008 · 4.6K citations
Robert L. Camp, Marisa Dolled‐Filhart, David L. Rimm · Clinical Cancer Research · 2004 · 3.9K citations
Medicine, Biostatistics, Oncology +17
1–5 of 35.2K
153.4K
56
h-index
50
h-index
The University of Texas MD Anderson Cancer Center, United States
74 publications · 10.1K citations
48
h-index
41
h-index
National and Kapodistrian University of Athens, Greece
71 publications · 4.5K citations
41
h-index
1–5 of 153.4K
11.3K
The University of Texas MD Anderson Cancer Center
Houston, United States
114 h-index
2.6K publications
231.7K citations

Johns Hopkins University
Baltimore, United States
114 h-index
1.7K publications
237.3K citations
Harvard University
Cambridge, United States
108 h-index
1.7K publications
313.8K citations
Memorial Sloan Kettering Cancer Center
New York, United States
102 h-index
1.7K publications
203K citations
National Cancer Institute
Bethesda, United States
102 h-index
1.4K publications
144.3K citations
Heidelberg University
Heidelberg, Germany
90 h-index
1.8K publications
131.6K citations
Inserm
Paris, France
89 h-index
2K publications
138.4K citations
National Institutes of Health
Bethesda, United States
87 h-index
997 publications
100K citations
1–8 of 11.3K
Repository · 4.5K publications · 241.7K citations
191
h-index
479 publications · 57.6K citations
127
h-index
858 publications · 62.1K citations
123
h-index
990 publications · 65.1K citations
118
h-index
BJC · 822 publications · 56.3K citations
116
h-index
1–5